文献速递流行病学与生物统计基础与转化研究

偶发影像学发现的患病率与结局:伞状综述

Prevalence and outcomes of incidental imaging findings: umbrella review.
PubMed 文献 · BMJ · 2018-06-18

该伞状综述汇总了20篇系统综述(240项原始研究),评估不同影像检查中偶发瘤的患病率及恶性率。偶发瘤患病率在检查间差异大(如心脏MRI>1/3,PET<5%),恶性率在器官间差异大(脑/腮腺/肾上腺<5%,乳腺42%)。结果有助于医患权衡影像检查利弊及偶发瘤管理决策。

要点

  • 偶发瘤患病率因影像检查而异,心脏MRI、胸部CT等可超过1/3,PET低于5%。
  • 偶发瘤恶性率因器官而异,乳腺最高(42%,95%CI 31%~54%),脑/腮腺/肾上腺低于5%。
  • 多数荟萃分析存在高异质性(15/20项I²>50%),结果解读需谨慎。

核心结论

  • 不同影像技术和器官间偶发瘤患病率及恶性率存在很大差异。

研究设计与样本

  • 伞状综述,检索MEDLINE和EMBASE至2017年8月,纳入20篇系统综述(240项原始研究)。

主要发现

  • 偶发瘤患病率:胸部CT incidental pulmonary embolism(伴/不伴癌症)和全身PET或PET/CT(伴/不伴癌症)低于5%。
  • 偶发瘤患病率:心脏MRI、胸部CT(胸部、腹部、脊柱或心脏偶发瘤)和CT结肠成像(结肠外偶发瘤)超过三分之一。
  • 偶发瘤患病率:脊柱MRI为22%,脑MRI为22%。
  • 恶性率:脑、腮腺和肾上腺偶发瘤低于5%;结肠外、前列腺和结肠偶发瘤为10%~20%;肾、甲状腺和卵巢偶发瘤约四分之一;乳腺偶发瘤最高(42%,95%CI 31%~54%)。
  • 15项荟萃分析I²>50%,提示研究间异质性高。

临床怎么用

  • 帮助临床医生和患者权衡申请影像扫描的利弊,并辅助偶发瘤诊断后的管理决策。
  • 结果可为制定相关指南提供依据。

局限性

  • 许多评估存在高研究间异质性(15/20项荟萃分析I²>50%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To provide an overview of the evidence on prevalence and outcomes of incidental imaging findings. DESIGN: Umbrella review of systematic reviews. DATA SOURCES: Searches of MEDLINE, EMBASE up to August 2017; screening of references in included papers. ELIGIBILITY CRITERIA: Criteria included systematic reviews and meta-analyses of observational studies that gave a prevalence of incidental abnormalities ("incidentalomas"). An incidental imaging finding was defined as an imaging abnormality in a healthy, asymptomatic patient or an imaging abnormality in a symptomatic patient, where the abnormality was not apparently related to the patient's symptoms. Primary studies that measured the prevalence of incidentalomas in patients with a history of malignancy were also considered in sensitivity analyses. RESULTS: 20 systematic reviews (240 primary studies) were identified from 7098 references from the database search. Fifteen systematic reviews provided data to quantify the prevalence of incidentalomas, whereas 18 provided data to quantify the outcomes of incidentalomas (13 provided both). The prevalence of incidentalomas varied substantially between imaging tests; it was less than 5% for chest computed tomography for incidental pulmonary embolism in patients with and without cancer and whole body positron emission tomography (PET) or PET/computed tomography (for patients with and without cancer). Conversely, incidentalomas occurred in more than a third of images in cardiac magnetic resonance imaging (MRI), chest computed tomography (for incidentalomas of thorax, abdomen, spine, or heart), and computed tomography colonoscopy (for extra-colonic incidentalomas). Intermediate rates occurred with MRI of the spine (22%) and brain (22%). The rate of malignancy in incidentalomas varied substantially between organs; the prevalence of malignancy was less than 5% in incidentalomas of the brain, parotid, and adrenal gland. Extra-colonic, prostatic, and colonic incidentalomas were malignant between 10% and 20% of the time, whereas renal, thyroid, and ovarian incidentalomas were malignant around a quarter of the time. Breast incidentalomas had the highest percentage of malignancy (42%, 95% confidence interval 31% to 54%). Many assessments had high between-study heterogeneity (15 of 20 meta-analyses with I2 >50%). CONCLUSIONS: There is large variability across different imaging techniques both in the prevalence of incidentalomas and in the prevalence of malignancy for specific organs. This umbrella review will aid clinicians and patients weigh up the pros and cons of requesting imaging scans and will help with management decisions after an incidentaloma diagnosis. Our results can underpin the creation of guidelines to assist these decisions. SYSTEMATIC REVIEW REGISTRATION: PROSPERO: CRD42017075679.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. O'Sullivan JW, Muntinga T, Grigg S, et al. Prevalence and outcomes of incidental imaging findings: umbrella review. BMJ. 2018. PMID: 29914908. doi:10.1136/bmj.k2387

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。